To revascularize or not to revascularize: a dilemma in heart failure

Senior, Roxy
August 2005
CMAJ: Canadian Medical Association Journal;8/15/2006, Vol. 175 Issue 4, p372
Academic Journal
The article comments on a study which compared the rate of death between patients with heart failure treated with revascularization and those who are treated with medical therapy. The methodology of the study is described. Clinical information on coronary revascularization is provided. The rate of death among patients with heart disease is also explored.


Related Articles

  • Treatment of heart failure with reduced left ventricular ejection fraction. Aronow, Wilbert S. // Geriatrics;Mar2006, Vol. 61 Issue 3, p22 

    Heart failure (HF) affects approximately 5 million persons in the United States each year. HF is predominantly a disease of the elderly: Approximately 80% of patients hospitalized with HF are older than age 65. Approximately one-half of older adult patients with CHF have a decreased ejection...

  • QTc Interval Prolongation Predicts Postoperative Mortality. Vrtovec, Bojan; Yazdanbakhsh, Aria P.; Pintar, Tatjana; Collard, Charles D.; Gregoric, Igor D.; Radovancevic, Branislav // Texas Heart Institute Journal;2006, Vol. 33 Issue 1, p3 

    QTc interval prolongation is associated with increased mortality rates in patients with advanced heart failure. We investigated the predictive value of prolonged QTc interval in 567 patients with heart failure who were undergoing coronary artery bypass graft surgery. The patients were in New...

  • Repeat intervention after invasive treatment of coronary arteries. Loponen, Pertti; Korpilahti, Kari; Luther, Michael; Huhtala, Heini; Tarkka, Matti R. // European Journal of Cardio-Thoracic Surgery;Jan2009, Vol. 35 Issue 1, p43 

    Abstract: Objective: Patients who undergo successful revascularisation either with coronary artery bypass grafting (CABG) or with percutaneous coronary intervention (PCI) may subsequently require repeat invasive procedures. Methods: A cohort of 662 coronary artery diseased (CAD) patients was...

  • Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience. Grundeken, Maik J.; Vis, M. Marije; Beijk, Marcel A. M.; Kikkert, Wouter J.; Damman, Peter; Kloek, Jaap J.; Baan Jr, Jan; Koch, Karel T.; Wykrzykowska, Joanna J.; Tijssen, Jan G. P.; de Mol, Bas A. J. M.; Henriques, Jose P. S.; Piek, Jan J.; de Winter, Robbert J. // Heart;May2013, Vol. 99 Issue 10, p690 

    Objectives We evaluated 30-day and 1-year clinical outcomes after percutaneous or surgical coronary revascularisation in patients with unprotected left main coronary artery (ULMCA)-related acute myocardial infarction (AMI). Design Single-centre registry. Patients Between January 1998 and...

  • Review: Cardiac resynchronization therapy reduces morbidity and mortality in left ventricular systolic dysfunction.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p58 

    The article focuses on a study, that focuses on the effects of cardiac resynchronization therapy (CRT) on patients with left ventricular systolic dysfunction (LVSD). It mentions the data sources used to conduct the study, the theory on which it is based and its outcome. It concludes that CRT led...

  • BiV Pacing in Class IV Heart Failure. DiMarco, John P. // Clinical Cardiology Alert;Mar2007, Vol. 26 Issue 3, p19 

    Cardiac resychronization therapy reduces morbidity and mortality in class IV heart failure patients.

  • Nesiritide for CHF May Increase Mortality Risk. Slawson, David // American Family Physician;8/1/2005, Vol. 72 Issue 3, p510 

    Discusses research being done on the efficacy of nesiritide in the treatment of patients with congestive heart failure. Reference to a study by J. D. Sackner-Bernstein and colleagues published in the April 20, 2005 issue of "Journal of American Medical Association"; Mortality rates among...

  • Beneficios clínicos de la resincronización cardiaca. Guevara-Valdivia, Milton E. // Archivos de Cardiología de México;2009 Supplement 2, Vol. 79 Issue 5, p71 

    Despite the improvement in pharmacologic treatment of heart failure, many patients continue to have severe persistent symptoms, and their prognosis remains poor. One of the most recent advances in heart failure management is the concept of cardiac resynchronization therapy (CRT). Large clinical...

  • Inotropes do not increase mortality in advanced heart failure. Guglin, Maya; Kaufman, Marc // International Journal of General Medicine;2014, Vol. 7, p237 

    Inotrope use is one of the most controversial topics in the management of heart failure. While the heart failure community utilizes them and recognizes the state of inotrope dependency, retrospective analyses and registry data have overwhelmingly suggested high mortality, which is logically to...


Read the Article


Sign out of this library

Other Topics